Tracheostomy during SARS‐CoV ‐2 pandemic: Recommendations from the New York Head and Neck Society

Author:

Miles Brett A.1ORCID,Schiff Bradley2,Ganly Ian3,Ow Thomas2,Cohen Erik4,Genden Eric1,Culliney Bruce1,Mehrotra Bhoomi5,Savona Steven6,Wong Richard J.3,Haigentz Missak4,Caruana Salvatore7,Givi Babak8,Patel Kepal8,Hu Kenneth9

Affiliation:

1. Department of Otolaryngology Head and Neck Surgery, Head and Neck Oncology DivisionIcahn School of Medicine at Mount Sinai New York New York USA

2. Montefiore Medical CenterAlbert Einstein College of Medicine Bronx New York USA

3. Memorial Sloan Kettering Cancer CenterWeill Cornell Medical College New York New York USA

4. Morristown Medical CenterLeonard B. Kahn Head and Neck Cancer Institute Morristown New Jersey USA

5. Department of Hematology Oncology, Head and Neck OncologyCancer Institute at St. Francis Hospital New York New York USA

6. Northwell Cancer InstituteMonter Cancer Center Lake Success New York USA

7. Department of Otolaryngology Head and Neck Surgery, Head and Neck Oncology Division, Columbia University New York New York USA

8. Department of Otolaryngology Head and Neck Surgery, Head and Neck Oncology Division, NYU Langone Health New York New York USA

9. Department of Hematology Oncology, Division Head and Neck OncologyNYU Langone Health New York New York USA

Publisher

Wiley

Subject

Otorhinolaryngology

Reference54 articles.

1. Outbreak of Novel Coronavirus (SARS-CoV-2): First Evidences From International Scientific Literature and Pending Questions

2. Insights into the recent 2019 novel coronavirus (SARS‐CoV‐2) in light of past human coronavirus outbreaks;Ashour HM;Pathogens,2020

3. SARS‐CoV‐2: a novel deadly virus in a globalised world;Dilcher M;N Z Med J,2020

4. The novel coronavirus (SARS‐CoV‐2) epidemic;Hsu LY;Ann Acad Med Singapore,2020

5. Induction of pro‐inflammatory cytokines (IL‐1 and IL‐6) and lung inflammation by Coronavirus‐19 (COVI‐19 or SARS‐CoV‐2): anti‐inflammatory strategies;Conti P;J Biol Regul Homeost Agents,2020

Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3